COLLEEN FAIRHURST: Open Payments
NPI 1093168114 · STOW, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,225 in 75 payments from 15 companies in 2025. Trend: 2023 $1,612 · 2024 $2,004 · 2025 $1,225
Food & beverage: $1,140Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $203 |
| ABBVIE INC. | 19 | $179 |
| GENZYME CORPORATION | 11 | $176 |
| LEO Pharma Inc. | 6 | $171 |
| Regeneron Healthcare Solutions, Inc. | 5 | $109 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| UCB, Inc. | 3 | $76 |
| Lilly USA, LLC | 3 | $61 |
| Organon LLC | 7 | $50 |
| Galderma Laboratories, L.P. | 2 | $32 |
Products named: DUPIXENT, TREMFYA, ADBRY, RINVOQ, SKYRIZI, EBGLYSS, Bimzelx, LIBTAYO.
Industry payments across OH — which companies pay providers there.
